All Stories

  1. Descemet's membrane endothelial keratoplasty with scraping without descemetorhexis (DMEK-SWD) in a failed penetrating keratoplasty
  2. Comparative efficacy of Nd : YAG laser peripheral iridotomy and surgical iridectomy in modulating perioperative subclinical inflammation after ...
  3. Corneal Stromal Thinning and Posterior Irregularity After DMEK: Clinical Observations and Biophysical Hypotheses
  4. Anterior Chamber Inflammation and Descemet Membrane Endothelial Keratoplasty
  5. Differential Diagnosis of Corneal Manifestations in Hypovitaminosis and Retinitis Pigmentosa
  6. Validation of a Deep Learning–Assisted Evaluation of Total Corneal Endothelial Cells Viability
  7. Congenital aniridia: European COST action ANIRIDIA‐NET guidelines for diagnosis, management and care
  8. Advanced imaging of corneal neovascularisation with a novel swept-source AS-OCTA system
  9. Atypical Endophthalmitis Following Artificial Corneal Endothelial Implantation
  10. Trypan blue-assisted iris cyst excision
  11. Evaluating the efficacy of postoperative topical antibiotics in cataract surgery: A systematic review and meta‐analysis
  12. Cataract surgery in megalocornea: A qualitative and quantitative evaluation of published literature
  13. Differentiation of human hyalocytes from induced pluripotent stem cells through ascorbic acid treatment
  14. Repeatability of Pentacam HR in Keratoconus According to Two Different Scan Protocols: 25-3D Scan and 50-Cornea Fine
  15. Suprachoroidal injection of triamcinolone acetonide as adjuvant to surgical treatment of epiretinal membrane
  16. Comparative Analysis of Tomographic Indicators Forecasting Decompensation in Fuchs Endothelial Corneal Dystrophy
  17. Life-threatening complications in ophthalmic surgery: a systematic review
  18. Corneal Artificial Endothelial Layer (EndoArt): Literature Review and Our Experience
  19. Off-Centered Descemet Membrane Endothelial Keratoplasty Grafts: Impact and Resolution
  20. Utilising Narrative Medicine to Identify Key Factors Affecting Quality of Life in Dry Eye Disease: An Italian Multicentre Study
  21. Natural history of cerebral visual impairment in children with cerebral palsy
  22. Preoperative Posterior Stromal Ripples as Predictive Biomarkers of Visual Recovery After Descemet Membrane Endothelial Keratoplasty
  23. Multimodal imaging and histopathological evaluation in silicone oil keratopathy
  24. The incidence of severe complications in acanthamoeba keratitis: Qualitative and quantitative systematic assessment
  25. Corneal manifestations in bariatric surgery-related hypovitaminosis
  26. Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications
  27. Quality assurance in corneal transplants: Donor cornea assessment and oversight
  28. Topical Antiseptics in Minimizing Ocular Surface Bacterial Load Before Ophthalmic Surgery: A Randomized Controlled Trial
  29. Open-source, 3D printable IOL holder for detailed, smartphone-based anterior segment photography
  30. Double trouble in DMEK surgery: Learning experience and review of the literature
  31. DMEK surgical training: An instructional guide on various wet-lab methods
  32. DMEK F-marking complication: case report and literature review
  33. Ocular phenotype and therapeutic interventions in keratitis-ichthyosis-deafness (KID) syndrome
  34. Preoperative surgeon evaluation of corneal endothelial status: the Viability Control of Human Endothelial Cells before Keratoplasty (V-CHECK) study protocol
  35. Antimicrobials and antiseptics: Lowering effect on ocular surface bacterial flora – A systematic review
  36. Artificial iris implantation in congenital aniridia: A systematic review
  37. Deep Learning Using Preoperative AS-OCT Predicts Graft Detachment in DMEK
  38. FGF-trapping hampers cancer stem-like cells in uveal melanoma
  39. Combined or sequential DMEK in cases of cataract and Fuchs endothelial corneal dystrophy—A systematic review and meta‐analysis
  40. A goat eye, wet lab model for training in Descemet membrane endothelial keratoplasty
  41. Incidence and management of early postoperative complications in lamellar corneal transplantation
  42. Role of Direct Supervision in the Learning Curve of Descemet Membrane Endothelial Keratoplasty Surgery
  43. Intraoperative OCT for Lamellar Corneal Surgery: A User Guide
  44. Predictability of the vault after implantable collamer lens implantation using OCT and artificial intelligence in White patient eyes
  45. Selective laser capsulotomy complications: Management and prevention
  46. Neurovisual profile in children affected by Angelman syndrome
  47. Diabetic Retinopathy: Soluble and Imaging Ocular Biomarkers
  48. Surgical goniolens for tag identification and removal in DMEK surgery
  49. Allogeneic Solid Platelet-Rich Plasma for Persistent Epithelial Neurotrophic Defects: A Protocol and Pilot Study
  50. Therapeutic Hyper-CL soft contact lens in Sjögren's syndrome
  51. COVID-19 and Clinically Isolated Syndrome: Coincidence or Causative Link? A 12-Month Follow-Up Case Report
  52. Comments on: Fine-needle diathermy for corneal vascularization
  53. Extended Overview of Ocular Phenotype with Recent Advances in Hypohidrotic Ectodermal Dysplasia
  54. Retinal and Corneal Changes Associated with Intraocular Silicone Oil Tamponade
  55. What empiric treatment should be given for suspected bacterial keratitis in Northern Italy?
  56. DMEK graft: One size does not fit all
  57. Myopia: Mechanisms and Strategies to Slow Down Its Progression
  58. COVID-19 AdenoviralVector Vaccine and Central Retinal Vein Occlusion
  59. Visual and Refractive Outcomes Following Laser Blended Vision With Non-linear Aspheric Micro-anisometropia (PRESBYOND) in Myopic and Hyperopic Patients
  60. Exploring the FGF/FGFR System in Ocular Tumors: New Insights and Perspectives
  61. Age-Related Effects on the Spectrum of Cerebral Visual Impairment in Children With Cerebral Palsy
  62. Update on Suture Techniques in Corneal Transplantation: A Systematic Review
  63. An Orthotopic Model of Uveal Melanoma in Zebrafish Embryo: A Novel Platform for Drug Evaluation
  64. SURGICAL OUTCOMES OF VITREOMACULAR TRACTION TREATED WITH FOVEAL-SPARING PEELING OF THE INTERNAL LIMITING MEMBRANE
  65. Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells
  66. Two-Year Changes in Corneal Spherical Aberration After Laser-Assisted In Situ Keratomileusis and Photorefractive Keratectomy in Regular and Wavefront-Guided Ablations
  67. Neurodevelopmental Profile in Children Affected by Ocular Albinism
  68. Early visual training and environmental adaptation for infants with visual impairment
  69. Risk factors for postoperative eye pain in patients with non-painful eye disease undergoing pars plana vitrectomy: the VItrectomy Pain (VIP) study
  70. A novel quantitative analysis method for idiopathic epiretinal membrane
  71. Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
  72. VEGF-Independent Activation of Müller Cells by the Vitreous from Proliferative Diabetic Retinopathy Patients
  73. Topography/wavefront-guided photorefractive keratectomy combined with crosslinking for the treatment of keratoconus: preliminary results
  74. Changes in pupillometry associated with dissipated energy during phacoemulsification
  75. Gene expression analysis identifies two distinct molecular clusters of idiopatic epiretinal membranes
  76. Effectiveness and Safety of Topical Chlorhexidine and Vitamin E TPGS in the Treatment of Acanthamoeba Keratitis: A Survey on 29 Cases
  77. Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform
  78. Effects of the first month of lockdown for COVID-19 in Italy: A preliminary analysis on the eyecare system from six centers
  79. FOVEA-SPARING VERSUS COMPLETE INTERNAL LIMITING MEMBRANE PEELING IN VITRECTOMY FOR THE TREATMENT OF MACULAR HOLES
  80. Pneumatic retinopexy preceded by drainage of subretinal fluid for the treatment of severe bullous retinal detachment
  81. PEELING OF THE INTERNAL LIMITING MEMBRANE WITH FOVEAL SPARING FOR TREATMENT OF DEGENERATIVE LAMELLAR MACULAR HOLE
  82. Correction: One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy
  83. One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy
  84. Ocular Refraction at Birth and Its Development During the First Year of Life in a Large Cohort of Babies in a Single Center in Northern Italy
  85. Effects of an antioxidant protective topical formulation on retinal tissue of UV-exposed rabbits
  86. Central Serous Chorioretinopathy: Pathogenesis and Management
  87. Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications
  88. EPIRETINAL MEMBRANE REMOVAL WITH FOVEAL-SPARING INTERNAL LIMITING MEMBRANE PEELING
  89. The Autocrine FGF/FGFR System in both Skin and Uveal Melanoma: FGF Trapping as a Possible Therapeutic Approach
  90. Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update
  91. Vascular Endothelial Growth Factor in the Vitreous of Proliferative Diabetic Retinopathy Patients: Chasing a Hiding Prey?
  92. Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications
  93. Treatment of exudative age‐related macular degeneration with aflibercept combined with pranoprofen eye drops or nutraceutical support with omega‐3: A randomized trial
  94. Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration
  95. Comparative assessment of intraocular inflammation following standard or heavy silicone oil tamponade: a prospective study
  96. POOR CONCORDANCE BETWEEN NON-INVASIVE AND LOCALLY INVASIVE TECHNIQUES OF EVALUATION OF MICROVASCULAR MORPHOLOGY IN THE DETECTION OF HYPERTROPHIC REMODELING OF SMALL RESISTANCE ARTERIES
  97. Comparison between invasive and noninvasive techniques of evaluation of microvascular structural alterations
  98. ranibizumab and indomethacin in neovascular age-related macular degeneration
  99. Carotid stiffness is significantly correlated with wall-to-lumen ratio of retinal arterioles
  100. New Methods to Study the Microcirculation
  101. Neonatal Assessment Visual European Grid (NAVEG): Unveiling neurological risk
  102. ILM peeling in nontractional diabetic macular edema: review and metanalysis
  103. 3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy
  104. [PP.09.17] REPRODUCIBILITY OF THE EVALUATION OF THE WALL TO LUMEN RATIO OF RETINAL ARTERIOLES WITH TWO DIFFERENT NON-INVASIVE APPROACHES
  105. Ocular fundus photography with a smartphone device in acute hypertension
  106. Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension
  107. Heavy and standard silicone oil: intraocular inflammation
  108. Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy
  109. Intravitreal Anti-Vascular Endothelial Growth Factor Drugs for Retinal Angiomatous Proliferation in Real-Life Practice
  110. Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans
  111. Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy
  112. Controversies over the role of internal limiting membrane peeling during vitrectomy in macular hole surgery
  113. Trace elements and diabetes: Assessment of levels in tears and serum
  114. Spectral-domain optical coherence tomography findings in idiopathic lamellar macular hole
  115. Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment
  116. Effect of Autologous Serum Eye Drops in Patients with Sjögren Syndrome-related Dry Eye: Clinical and In Vivo Confocal Microscopy Evaluation of the Ocular Surface
  117. Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia
  118. Relationship Between Different Subpopulations of Circulating CD4+T-lymphocytes and Microvascular Structural Alterations in Humans
  119. Comparison of Smartphone Ophthalmoscopy With Slit-Lamp Biomicroscopy for Grading Vertical Cup-to-Disc Ratio
  120. [PP.21.05] RELATIONSHIP BETWEEN MICROVASCULAR STRUCTURE AND T REGULATORY LYMPHOCYTES OF SMALL RESISTANCE ARTERIES
  121. [OP.8D.06] OCULAR FUNDUS PHOTOGRAPHY WITH A SMARTPHONE DEVICE IN ACUTE HYPERTENSION
  122. Morphological and Functional Retinal Assessment in Epiretinal Membrane Surgery
  123. From the analysis of pharmacologic vitreolysis to the comprehension of ocriplasmin safety
  124. Zebrafish ( Danio rerio ) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases
  125. REDUCTION OF VITREOUS PROSTAGLANDIN E2 LEVELS AFTER TOPICAL ADMINISTRATION OF INDOMETHACIN 0.5%, BROMFENAC 0.09%, AND NEPAFENAC 0.1%
  126. Arteriolar Diameters in Glaucomatous Eyes with Single-Hemifield Damage
  127. Morphological and clinical characteristics of myopic posterior staphyloma in Caucasians
  128. Assessment of a smartphone-based camera for fundus imaging in animals
  129. INDICATIONS AND RESULTS OF A NEW L-SHAPED MACULAR BUCKLE TO SUPPORT A POSTERIOR STAPHYLOMA IN HIGH MYOPIA
  130. Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection
  131. Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration
  132. TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH RANIBIZUMAB COMBINED WITH KETOROLAC EYEDROPS OR PHOTODYNAMIC THERAPY
  133. Efficacy and vitreous levels of topical NSAIDs
  134. PP.27.10
  135. Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy
  136. Effect of intravitreal ranibizumab injections on aqueous humour concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in patients with myopic choroidal neovascularisation
  137. Therapeutic Potential of Anti-Angiogenic Multitarget N,O -Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy
  138. Comparison of Smartphone Ophthalmoscopy With Slit-Lamp Biomicroscopy for Grading Diabetic Retinopathy
  139. Development of ocular hypertension secondary to tamponade with light versus heavy silicone oil: A systematic review
  140. A Novel Device to Exploit the Smartphone Camera for Fundus Photography
  141. Current Trends about Inner Limiting Membrane Peeling in Surgery for Epiretinal Membranes
  142. Diabetic Retinopathy: Vascular and Inflammatory Disease
  143. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy
  144. Effects of a Long-Term Treatment With Aliskiren or Ramipril on Structural Alterations of Subcutaneous Small-Resistance Arteries of Diabetic Hypertensive Patients
  145. Diameters and Wall-to-Lumen Ratio of Retinal Arterioles in Patients with Retinal Vein Occlusion Before and After Treatment with Dexamethasone Intravitreal Implants
  146. Effect of Palmitoylethanolamide on Visual Field Damage Progression in Normal Tension Glaucoma Patients: Results of an Open-Label Six-Month Follow-Up
  147. Cystoid macular edema after pars plana vitrectomy for idiopathic epiretinal membrane
  148. Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview
  149. Relationship of Wall-to-Lumen Ratio of Retinal Arterioles With Clinic and 24-Hour Blood Pressure
  150. Correlation between clinic and 24 hours blood pressure and wall-to-lumen ratio of retinal arterioles
  151. Infliximab
  152. Acute Dacryocystitis with Empyema of the Lacrimal Sac
  153. 5th International meeting on angiogenesis
  154. Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis
  155. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension
  156. Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation
  157. Quality of vision in patients implanted with aspherical and spherical intraocular lens: Intraindividual comparison
  158. Tamponade or Filling Effect: Changes of Forces in Myopic Eyes
  159. Heavy Silicone Oil and Intraocular Inflammation
  160. Etiopathogenesis and Therapy of Epithelial Ingrowth after Descemet’s Stripping Automated Endothelial Keratoplasty
  161. Some Physicochemical Remarks on Spontaneous Emulsification of Vitreal Tamponades
  162. Evaluation of the Efficacy of 50% Autologous Serum Eye Drops in Different Ocular Surface Pathologies
  163. Macular Edema and Silicone Oil Tamponade
  164. Cognitive Dysfunction and Age-Related Macular Degeneration
  165. Clinical Analysis of Macular Edema with New Software for SD-OCT Imaging
  166. In vitro and ex vivo retina angiogenesis assays
  167. Neurotrophic Keratitis
  168. Ocular tissues and fluids oxidative stress in hares fed on verbascoside supplement
  169. Myopia onset and progression: can it be prevented?
  170. High doses of cobalt induce optic and auditory neuropathy
  171. Acute Dacryocystitis with Empyema of the Lacrimal Sac: Is Immediate Endoscopic Dacryocystorhinostomy Justified?
  172. Relationship between wall-to-lumen ratio of retimal arterioles and clinic and 24 hours blood pressure
  173. Aflibercept in wet AMD: specific role and optimal use
  174. Incidence rates of surgically treated rhegmatogenous retinal detachment among manual workers, non-manual workers and housewives in Tuscany, Italy
  175. A randomised controlled trial of ranibizumab with and without ketorolac eyedrops for exudative age-related macular degeneration
  176. Familial Exudative Vitreoretinopathy caused by a Homozygous Mutation inTSPAN12in a Cystic Fibrosis Infant
  177. A novel ex vivo murine retina angiogenesis (EMRA) assay
  178. Corneal oedema and its medical treatment
  179. Aqueous humor levels of vascular endothelial growth factor and adiponectin in patients with type 2 diabetes before and after intravitreal bevacizumab injection
  180. Novel aspects of Sjögren’s syndrome in 2012
  181. Recurrent Central Serous Chorioretinopathy after Peripheral Retinal Laser Photocoagulation: A Case Report
  182. INTRAVITREAL PEGAPTANIB SODIUM (MACUGEN) FOR TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION
  183. Central Retinal Vein Occlusion Treated with Ozurdex: A Case Report and Review of Literature
  184. Inflammation and Macular Oedema after Pars Plana Vitrectomy
  185. Erythropoietin and Diabetic Retinopathy
  186. Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema
  187. Vitreous Mediators in Retinal Hypoxic Diseases
  188. Mechanism of Inflammation in Age-Related Macular Degeneration: An Up-to-Date on Genetic Landmarks
  189. Proliferative Vitreoretinopathy after Eye Injuries: An Overexpression of Growth Factors and Cytokines Leading to a Retinal Keloid
  190. Short-time prone posturing is well-tolerated and reduces the rate of unintentional retinal displacement in elderly patients operated on for retinal detachment
  191. TNF-Alpha Levels in Tears: A Novel Biomarker to Assess the Degree of Diabetic Retinopathy
  192. P1.16 CORRELATION BETWEEN WALL-TO-LUMEN RATIO OF RETINAL ARTERIOLES AND CLINIC AND 24 HOURS BLOOD PRESSURE
  193. Intravitreal pegaptanib sodium (Macugen®) for treatment of diabetic macular oedema: a morphologic and functional study
  194. Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chronic central serous chorioretinopathy
  195. Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration
  196. Identification of mRNAs and proteins specifically associated with transformation in ocular malignant melanoma cells
  197. Correlation between visual acuity and OCT-measured retinal nerve fiber layer thickness in a family with ADOA and an OPA1 mutation
  198. Relationship between media-to-lumen ratio of subcutaneous small arteries and wall-to-lumen ratio of retinal arterioles evaluated noninvasively by scanning laser Doppler flowmetry
  199. Consensus on the diagnosis, treatment and follow-up of patients with age-related macular degeneration eligible for ranibizumab
  200. Defining reference values of trace elements in the tear film: Diagnostic methods and possible applications
  201. Reduction in retinal nerve fiber layer thickness in migraine patients
  202. Pseudo-Foster Kennedy syndrome in a young woman with meningioma infiltrating the superior sagittal sinus
  203. Proteomic Analyses of the Vitreous Humour
  204. Vitreous Analysis in the Management of Uveitis
  205. Mechanism of Inflammation in Age-Related Macular Degeneration
  206. 3.5 EFFECT OF SHORT-TERM TREATMENT WITH LERCANIDIPINE ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND STRUCTURAL ALTERATIONS IN RETINAL ARTERIOLES
  207. Structural Alterations in Small Resistance Arteries in Obesity
  208. Retinal Angiomatosis and Cystoid Macular Oedema in Coganʼs Syndrome
  209. Systemic Adverse Drug Reactions Secondary to Anti-VEGF Intravitreal Injection in Patients with Neovascular Age-Related Macular Degeneration
  210. Predicting the risk of diabetic retinopathy in type 2 diabetic patients
  211. Genetic Predictors of Response to Photodynamic Therapy
  212. Therapeutic Challenges to Retinitis Pigmentosa: From Neuroprotection to Gene Therapy
  213. Isolated sphenoid inflammatory diseases associated with visual impairment: 15-year experience at a single institution
  214. Clinical Evidence of Intravitreal Triamcinolone Acetonide in the Management of Age-Related Macular Degeneration
  215. Combined photodynamic therapy and intravitreal bevacizumab for idiopathic polypoidal choroidal vasculopathy: one-year follow-up
  216. Impact of Coagulation-Balance Gene Predictors on Efficacy of Photodynamic Therapy for Choroidal Neovascularization in Pathologic Myopia
  217. Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
  218. Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration
  219. INTRAVITREAL BEVACIZUMAB FOR TREATMENT-NAÏVE PATIENTS WITH SUBFOVEAL OCCULT CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION
  220. Changes in neovascular choroidal morphology after intravitreal bevacizumab injection: prospective trial on 156 eyes throughout 12-month follow-up
  221. Endophthalmitis
  222. Multiple Strokes in a Newborn
  223. Selective Serotonin Reuptake Inhibitors: A Review of its Effects on Intraocular Pressure
  224. Intravitreal bevacizumab (Avastin®) injection for neovascular glaucoma: a survey on 23 cases throughout twelve-month follow-up
  225. Gonioscopic Findings in Patients with Type 1 Neurofibromatosis (Von Recklinghausen Disease)
  226. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma
  227. Color Doppler Imaging of Ophthalmic Artery Blood Flow Velocity
  228. Diplopie Iatrogenique: Possible Responsabilite Professionelle
  229. Severe Corneoconjunctival Xerosis After Biliopancreatic Bypass for Obesity (Scopinaro's Operation)
  230. Cocaine-associated retinal vascular occlusion: Report of two cases
  231. Analysis of fibronectin, plasminogen activators and plasminogen in tear fluid as markers of corneal damage and repair